Navigation Links
The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
Date:6/1/2009

DOYLESTOWN, Pa. June 1 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com, today announced that IVS Associates, Inc., the inspector of election for Quigley's 2009 annual meeting of shareholders, issued its final report, showing that Ted Karkus' seven director nominees received a larger number of votes than Quigley's incumbent directors.

The Company also announced that despite the final voting results issued today by IVS, the final outcome of the director election remains uncertain. On May 19, 2009, one day before the Company's 2009 Annual Meeting, the Company announced it had uncovered an undisclosed financial arrangement between Karkus and the Company's Quigley Pharma, Inc. subsidiary COO, Dr. Richard A. Rosenbloom. Karkus had previously stated in sworn testimony that at no time did he have any financial arrangement with any employee of The Quigley Corporation. Since the Annual Meeting, the Company has learned that Dr. Rosenbloom may have also had undisclosed financial arrangements with one of Karkus' director nominees and with John Ligums, an alleged member of the Karkus Group.

On May 29, 2009, upon a motion by the Company detailing these recent developments, the District Court Judge in the United States District Court for the Eastern District of Pennsylvania ordered the Company to operate under a standstill agreement with respect to the composition of the Company's Board of Directors pending a Court hearing on the motion. The Company expects the motion will be heard by Friday, June 5, 2009.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY,

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
2. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
3. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
4. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
5. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
6. The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus Solicitation Efforts
7. The Quigley Corporation Reports First Quarter 2009 Results
8. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
9. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
10. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
11. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Eric J. Hall, president and chief e...America (AFA) issued the following statement regar...on as part of the new annual wellness for Medicare... Affordable Care Act" that was introduced las...PRWEB) November 21, 2009 -- Eric J. Hall, presiden...
(Date:11/20/2009)...Pioneering Neurologist Closer to Understanding Bra...PRNewswire-USNewswire/ -- Dr. Jeremy Schmahmann, P...d neurologist at the Massachusetts General Hospita...is laboratory,s research on the new field of study...nk Foundation. ,, Dr. Schmahmann is an award-wi...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -... urged the Senate to make essential changes its he... law on abortion funding and conscience protection...migrants and include strong provisions for adequat...te health care bill an "enormous disappointment" t...
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -...rus may have peaked in late October, but the pande...f illness in all age groups, including the elderly...ncorporated (NYSE: DGX ), the world,s leading pr...ices. ,, In its most recent Quest Diagnostics ...
(Date:11/20/2009)..., HAIFA, Israel, November 20 /PRNewswire-Firs...SL.OB), http://www.CVSLMEDICAL.COM , a leading,de...ogy, today announced that,the company,s Board of D...ns,in Europe, Canada and the Far East for its prop...icable for all angioplasty (PCTA) procedures. ,...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
... Gujarat Government seeks to bring down infant and...lth program. As many as 5,000 // mothers and 72,0...ate. Through this new program named Chiranj... mortality rate to come down to 30 per thousand bi...
...porters of the Communist Party of India-Marxist (C...January 2006. The supporters of the guru are // ...MP Brinda Karat, who leveled charges that the medi...the office of the party. Health Minister ...
...what can be called as a rare feat, cardio-thoracic...ormed surgical correction of a congenital heart de... anesthesia’. // This surgery has so far been done...ng the entire surgery. The sensation of pain would...
...ect injection of chemotherapeutic agents into dire...onal intravenous route, seems to be // associated...ents, according to a latest study. // Ovari...f treatment for all ovarian cancer patients. ...
... incidence of waterborne diseases and food poisoni...ummer. An increase in the number of malaria cases ... cases is hoped to soar particularly, as people wo...bility of a well-developed public health system in...
...ted Kingdom Ministry is planning for reduction of ...re surgery. The Government is planning to reduce t... weeks from time of admission to NHS. Government i...tic and scan tests and also have to wait for speci...
Other Medicine News:Health News:Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy 2Health News:Rise In Waterborne And Malaria Cases Anticipated In Britain 2
(Date:11/19/2009)... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- S...rmaceutical ingredients (APIs), announced that its...Safety Certification from,SafeBridge(R) Consultant...mpetency and proficiency in the safe handling of p...d applies to specific laboratories and,production ...
(Date:11/19/2009)...BBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ -... ABT ) as one of its Most Admired Corporate Dealm... honored Abbott as its Most Admired Dealmaker in p... of acquisitions and divestitures since January 20...d its business portfolio with a focus on high-grow...
(Date:11/19/2009)... Part of International Internet Week of Action ,...swire/ -- The U.S. Food and Drug Administration to...al effort, called the International Internet Week ... involving medical products. ,, (Logo: http://..., During the effort, the FDA,s Office of Crimina...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Spectros Signs New International Distribution Deals 10418 1Spectros Signs New International Distribution Deals 10418 2Hospital Workers May Trigger Dangerous Outbreaks 59765 1Hospital Workers May Trigger Dangerous Outbreaks 59765 2Hospital Workers May Trigger Dangerous Outbreaks 59765 3Detecting the undetectable in prostate cancer screening 59761 1Detecting the undetectable in prostate cancer screening 59761 2Detecting the undetectable in prostate cancer screening 59761 3Detecting the undetectable in prostate cancer screening 59761 4
...l., Jan. 26 Data published online,today in Circul...ating the,XIENCE V(TM) Everolimus Eluting Coronary...ading XIENCE V outperforms the TAXUS(R) Express2(T...) in reducing major adverse,cardiac events (MACE) ...tients, XIENCE V demonstrated a 45 percent reducti...
...dentified, Versus Men , , NEW YORK, Jan. 26 Hype...isease that creates a thickening of the heart wall... death in children and young adults (<40). Mor...r one killer in women, the Hypertrophic Cardiomyop...in untreated for cardiac disease for decades, even...
Other Medicine Technology:Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 2Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 3Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 4Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 5Cardiac Disease in Women Remains Untreated for Decades 2
... American standard, corrected curve trial lenses a...ed in Marco refractors and are invaluable in treat...ets of other manufacturers contain a disproportion...which are less expensive to produce, and fewer len...
Marco LM-990A
LM-770 Digital Projection Lensemeter
EPIC
Medicine Products: